Official announcements
Recall
|
Medicines
|
19/09/2016
In a letter dated 19.09.2016, the marketing authorization holder informed its customers that yellow-brownish particles had been detected in the above batch and that a recall was therefore being carried out. The particles are traces of corrosion…
Recall
|
Medicines
|
16/09/2016
The marketing authorization holder informed its supplied customers in a letter dated 13.09.2016 that its batch of "Chlorhexidine digluconate Sage 20 mg/ml impregnated wipe" must be recalled as it is possibly microbiologically contaminated withbecause…
Safety warnings
|
Blood & Tissue
|
15/09/2016
The Federal Office for Public Health Safety has been informed by the Italian authority that WNV NAT testing will now be carried out in the provinces of Alessandria and Novara (Piedmont Region) in addition to the regions already announced.
Safety warnings
|
Blood & Tissue
|
08/09/2016
On 31 August 2016 the autonomous Community of Madrid, Spain, reported two cases of infection with Crimean–Congo haemorrhagic fever(CCHF) virus.
Safety warnings
|
Blood & Tissue
|
06/09/2016
The Federal Office for Public Health Safety has been informed by the Italian authority that WNV NAT testing will now be carried out in the province of Vercelli (Piedmont Region) in addition to the regions already announced.
Safety warnings
|
Medicines
|
06/09/2016
Novo Nordisk is recalling 55 lots of GlucaGen HypoKit worldwide because in some cases the needle has come loose from the pre-filled syringe. In Austria, one batch is affected.
Recall
|
Medicines
|
06/09/2016
The marketing authorization holder has informed its customers as well as pharmacies, institutional pharmacies, physicians in private practice and patient organizations by letter dated 06.09.2016 that there is a possibility of a detached needle from…
Safety warnings
|
Blood & Tissue
|
31/08/2016
The Federal Office for Safety in Health Care has been informed by the Italian authority that WNV NAT testing will now be carried out in the province of Vicenza (Veneto Region) in addition to the regions already announced.
Safety warnings
|
Blood & Tissue
|
30/08/2016
Given the current circulation of Zika virus ,the evidence of an association between Zika virus infection during pregnancy and congenital malformations of the central nervous system (CNS), the association between Zikavirus infection and Guillain–Barré syndrome(GBS)and the risk of local vector-borne transmission in Europe during the 2016 summer season, EU/EEA Member States should consider a range of mitigation measures.
Safety warnings
|
Blood & Tissue
|
26/08/2016
The Federal Office for Safety in Health Care has been informed by the Italian authority that WNV NAT testing will now be carried out in the province of Milano (Lombardia Region) in addition to the regions already announced.